Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis ...

Investing.com -- Viatris Inc. (NASDAQ: VTRS) stock fell 3.6% after the company announced that its Phase 3 study of MR-139 for blepharitis did not meet its primary endpoint. The randomized, double ...

From 2017 to 2022, the number of women in trades rose from about 241,000 to nearly 354,000. That’s an increase of about 47%. Even so, women still constitute just 5.3% of welders in the United ...

Denifanstat showed positive Phase 3 results in acne, meeting all goals with strong safety, as Sagimet pushes ahead with a second FASN inhibitor trial.

NAPOLI 3, a phase 3 study of NALIRIFOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Final overall survival (OS) analysis and characteristics of the long-term survivors.

Phase 3 trial shows vepdegestrant improves progression-free survival in metastatic breast cancer patients with ESR1 mutations versus fulvestrant. Quiver AI Summary Arvinas, Inc. and Pfizer, Inc ...

The I-20 project is in phase 3, meaning drivers are closer than ever to being able to drive on a resurfaced interstate. "So I-20 is actually progressing quite well.

About the phase 3 COMP005 trial To date, the COMP005 trial is the largest, multi-center study of an investigational, synthesized psilocybin to complete recruitment and will be the first pivotal ...

The month of April offers the most options to fix fantasy lineups due to changing MLB jobs and injuries.

Sotyktu significantly outperformed placebo for the treatment of psoriatic arthritis in a phase 3 trial, meeting key endpoints at 16 weeks, according to late-breaking data presented at the American ...

Neuroscientists have produced the largest wiring diagram and functional map of a mammalian brain to date using tissue from a part of a mouse's cerebral cortex involved in vision, an achievement ...

This phase 3 trial provided evidence for the efficacy and safety of inebilizumab in adults with generalized myasthenia gravis. Improvements in the inebilizumab group were apparent across outcome ...